Sonnet BioTherapeutics I... (SONN)
undefined
undefined%
At close: undefined
1.73
-0.56%
After-hours Jan 03, 2025, 05:09 PM EST

Sonnet BioTherapeutics Inc. Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for SONN stock have an median target of 38, with a low estimate of 20 and a high estimate of 56. The median target predicts an increase of 2083.91% from the current stock price of 1.74.

Analyst Consensus: Buy
Target Low Average Median High
Price $20 $38 $38 $56
Change 1049.43% 2083.91% 2083.91% 3118.39%

AI Analyst Report

Chardan Capital maintains a Buy rating on Sonnet B... Unlock content with Pro Subscription

Updated Dec 20, 2024

Rating Feb 24May 24Aug 24Dec 24
Strong Buy 0000
Buy 1211
Hold 0000
Sell 0000
Strong Sell 0000
Total 1 2 1 1

Financial Forecast this Year

Revenue This Year
42.54K
from -
Increased by ∞B%
Revenue Next Year
22.82K
from 42.54K
Increased by -46.4%
EPS This Year
-1.87
from null
Increased by -∞B%
EPS Next Year
-98.56
from -1.87
Increased by -5.17K%